• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

淋巴细胞白血病和败血症患者的死亡率趋势及人口统计学差异

Mortality Trends and Demographic Disparities Among Patients With Lymphoid Leukemia and Septicemia.

作者信息

Undhad Hiral, Joshi Pooja, Patil Nidhi, Uppal Neha, Bedi Simranjeet

机构信息

Internal Medicine, Jiangsu University School of Medicine, Zhenjiang, CHN.

Medicine, Kanti Devi Medical College, Hospital and Research Center, Mathura, IND.

出版信息

Cureus. 2025 Sep 9;17(9):e91920. doi: 10.7759/cureus.91920. eCollection 2025 Sep.

DOI:10.7759/cureus.91920
PMID:40937017
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12422165/
Abstract

INTRODUCTION

Lymphoid leukemia is a major cause of death, and its link with septicemia is progressively studied. It is crucial to understand that the relationship is important for identifying high-risk populations and designing targeted public health interventions.

AIMS

This study aims to evaluate mortality trends in lymphoid leukemia with septicemia as a contributing cause of death, using the CDC Multiple Causes of Death (MCD) database.

METHODOLOGY

A study retrospectively examined data from the CDC MCD database to determine trends in deaths among individuals 25 years and older in the US from 1999 through 2020. They examined deaths with lymphoid leukemia as the underlying cause of death and septicemia as a contributing cause. The data were categorized by sex, race, geographic region, and location of death. Age-adjusted mortality rate (AAMR) and annual percentage change (APC) were calculated.

RESULTS

From 1999 to 2020, 17,265 adults over 25 died with lymphoid leukemia and septicemia. Most deaths occurred in metropolitan areas (N = 14,267, 82.6%). Males (N = 10,825, 62.7%) and White individuals (N = 14,953, 86.6%) had the highest mortality. The crude death rate was 3.9 per million population.

CONCLUSION

This study highlights significant mortality trends increasing in lymphoid leukemia with septicemia with disparities by gender and race. Findings underscore the need for targeted prevention strategies and improved healthcare access.

摘要

引言

淋巴样白血病是主要死因之一,其与败血症的关联正逐步得到研究。了解这种关系对于识别高危人群和设计有针对性的公共卫生干预措施至关重要。

目的

本研究旨在利用美国疾病控制与预防中心(CDC)的多重死因(MCD)数据库,评估以败血症作为促成死因的淋巴样白血病的死亡率趋势。

方法

一项研究回顾性分析了CDC MCD数据库中的数据,以确定1999年至2020年美国25岁及以上人群的死亡趋势。他们研究了以淋巴样白血病为根本死因且败血症为促成死因的死亡情况。数据按性别、种族、地理区域和死亡地点进行分类。计算了年龄调整死亡率(AAMR)和年度百分比变化(APC)。

结果

1999年至2020年,17265名25岁以上成年人死于淋巴样白血病和败血症。大多数死亡发生在大都市地区(n = 14267,82.6%)。男性(n = 10825,62.7%)和白人个体(n = 14953,86.6%)的死亡率最高。粗死亡率为每百万人口3.9人。

结论

本研究突出了以败血症为促成死因的淋巴样白血病死亡率显著上升的趋势,且存在性别和种族差异。研究结果强调了制定针对性预防策略和改善医疗服务可及性的必要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/776d/12422165/99e8cbf91aee/cureus-0017-00000091920-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/776d/12422165/19cc93d060f5/cureus-0017-00000091920-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/776d/12422165/b65251f464ae/cureus-0017-00000091920-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/776d/12422165/99e8cbf91aee/cureus-0017-00000091920-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/776d/12422165/19cc93d060f5/cureus-0017-00000091920-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/776d/12422165/b65251f464ae/cureus-0017-00000091920-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/776d/12422165/99e8cbf91aee/cureus-0017-00000091920-i03.jpg

相似文献

1
Mortality Trends and Demographic Disparities Among Patients With Lymphoid Leukemia and Septicemia.淋巴细胞白血病和败血症患者的死亡率趋势及人口统计学差异
Cureus. 2025 Sep 9;17(9):e91920. doi: 10.7759/cureus.91920. eCollection 2025 Sep.
2
Mortality trends of renal diseases due to hypertension in adults: an analysis of gender, race, place of death, and geographical disparities in the United States from 1999 to 2020.成人高血压所致肾脏疾病的死亡率趋势:对1999年至2020年美国的性别、种族、死亡地点及地理差异的分析
Int Urol Nephrol. 2025 Apr 4. doi: 10.1007/s11255-025-04493-3.
3
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
4
Temporal Trends in Mortality Related to Hyperthyroidism and Heart Failure in the United States.美国甲状腺功能亢进症和心力衰竭相关死亡率的时间趋势
Cureus. 2025 Jun 18;17(6):e86274. doi: 10.7759/cureus.86274. eCollection 2025 Jun.
5
Mortality Related to Pneumonia and Diabetes Mellitus: A Retrospective Study.与肺炎和糖尿病相关的死亡率:一项回顾性研究
Cureus. 2025 Jul 31;17(7):e89169. doi: 10.7759/cureus.89169. eCollection 2025 Jul.
6
Trends in mortality of renal failure in adult multiple myeloma patients: a CDC data analysis (1999-2020).成年多发性骨髓瘤患者肾衰竭死亡率趋势:美国疾病控制与预防中心数据分析(1999 - 2020年)
Int Urol Nephrol. 2025 Sep 11. doi: 10.1007/s11255-025-04788-5.
7
Trends in United States mortality among patients with atrial fibrillation/flutter related heart failure (1999-2024): disparities by gender, race/ethnicity and region.美国心房颤动/扑动相关心力衰竭患者的死亡率趋势(1999 - 2024年):按性别、种族/族裔和地区划分的差异
BMC Cardiovasc Disord. 2025 Jul 31;25(1):558. doi: 10.1186/s12872-025-05036-5.
8
Epidemiological trends in diabetic renal complications in United States adults: A center for disease control and prevention wide-ranging online data for epidemiologic research analysis (1999-2020).美国成年人糖尿病肾脏并发症的流行病学趋势:疾病控制与预防中心广泛的在线流行病学研究分析数据(1999 - 2020年)
World J Nephrol. 2025 Jun 25;14(2):105815. doi: 10.5527/wjn.v14.i2.105815.
9
Surveillance for Violent Deaths - National Violent Death Reporting System, 48 States, the District of Columbia, and Puerto Rico, 2020.暴力死亡监测 - 全国暴力死亡报告系统,2020 年,48 个州、哥伦比亚特区和波多黎各。
MMWR Surveill Summ. 2023 May 26;72(5):1-38. doi: 10.15585/mmwr.ss7205a1.
10
Hypertension and sleep apnea as contributor to mortality trends in the United States: CDC WONDER data analysis.高血压和睡眠呼吸暂停对美国死亡率趋势的影响:疾病控制与预防中心(CDC)的数据分析
Sleep Med. 2025 Aug 21;135:106742. doi: 10.1016/j.sleep.2025.106742.

本文引用的文献

1
Analysis of lymphocytic leukemia trends among gender, race, age, and regional groups in the U.S. between 1999-2022: a CDC-WONDER database study.1999 - 2022年美国不同性别、种族、年龄和地区人群中淋巴细胞白血病趋势分析:一项疾控中心-WONDER数据库研究
Front Oncol. 2025 May 29;15:1555949. doi: 10.3389/fonc.2025.1555949. eCollection 2025.
2
Causal pathways in lymphoid leukemia: the gut microbiota, immune cells, and serum metabolites.淋巴性白血病的因果途径:肠道微生物群、免疫细胞和血清代谢物。
Front Immunol. 2024 Sep 16;15:1437869. doi: 10.3389/fimmu.2024.1437869. eCollection 2024.
3
Sepsis mortality among patients with haematological malignancy admitted to intensive care 2000-2022: a binational cohort study.
2000-2022 年收治于重症监护病房的血液恶性肿瘤患者的脓毒症死亡率:一项两国队列研究。
Crit Care. 2024 May 6;28(1):148. doi: 10.1186/s13054-024-04932-0.
4
Palliative and End-of-Life Care in Hematologic Malignancies: Progress and Opportunities.血液恶性肿瘤的姑息治疗和终末期照护:进展与机遇。
JCO Oncol Pract. 2024 Jun;20(6):739-741. doi: 10.1200/OP.24.00081. Epub 2024 Mar 13.
5
Institutional Structures and Processes to Support Sepsis Care: A Multihospital Study.支持脓毒症护理的机构结构与流程:一项多医院研究
Crit Care Explor. 2023 Nov 9;5(11):e1004. doi: 10.1097/CCE.0000000000001004. eCollection 2023 Nov.
6
Investigating causes and risk factors of pre-chemotherapy viremia in acute lymphoblastic leukemia pediatric patients.研究急性淋巴细胞白血病儿科患者化疗前病毒血症的病因和危险因素。
Infection. 2023 Feb;51(1):203-211. doi: 10.1007/s15010-022-01878-9. Epub 2022 Jul 25.
7
Rural Patients With Severe Sepsis or Septic Shock Who Bypass Rural Hospitals Have Increased Mortality: An Instrumental Variables Approach.绕过乡村医院的严重脓毒症或脓毒性休克乡村患者死亡率增加:一种工具变量法
Crit Care Med. 2017 Jan;45(1):85-93. doi: 10.1097/CCM.0000000000002026.
8
Infectious complications in chronic lymphocytic leukemia.慢性淋巴细胞白血病的感染并发症。
Mediterr J Hematol Infect Dis. 2012;4(1):e2012070. doi: 10.4084/MJHID.2012.070. Epub 2012 Nov 5.
9
Therapy of chronic lymphocytic leukaemia.慢性淋巴细胞白血病的治疗。
Best Pract Res Clin Haematol. 2010 Mar;23(1):85-96. doi: 10.1016/j.beha.2009.12.002.
10
Infectious complications in patients with chronic lymphocytic leukemia: pathogenesis, spectrum of infection, and approaches to prophylaxis.慢性淋巴细胞白血病患者的感染并发症:发病机制、感染谱及预防方法
Clin Lymphoma Myeloma. 2009 Oct;9(5):365-70. doi: 10.3816/CLM.2009.n.071.